A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Conditions
Amyotrophic Lateral Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UZ Leuven, Leuven, Belgium
Contact: Principal Investigator (Philip Van Damme)University Hospital - London Health Sciences Centre, London, Canada
Contact: Principal Investigator (Christen Shoesmith)McGill University Health Centre, Montreal, Canada
Contact: Principal Investigator (Angela Genge)Sunnybrook Research Institute, Toronto, Canada
Contact: Principal Investigator (Agessandro Abrahao)Universitätsklinikum Schleswig-Holstein, Lübeck, Germany
Contact: Principal Investigator (Julian Grosskreutz)Universitätsmedizin Rostock, Rostock, Germany
Contact: Principal Investigator (Andreas Hermann)Universitaetsklinikum Ulm, Ulm, Germany
Contact: Principal Investigator (Jochen Weishaupt)Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
Contact: Principal Investigator (Leonard H. Berg)Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain
Contact: Principal Investigator (MONICA POVEDANO PANADES)Hospital Universitari i Politecnic La Fe, Valencia, Spain
Contact: Principal Investigator (Juan Vazquez-Costa)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company